XML 115 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2023
shares
Dec. 31, 2023
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Dr. Luis von Ahn [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On November 30, 2023, Dr. Luis von Ahn, Chief Executive Officer, and the Luis von Ahn Foundation, of which Dr. von Ahn is the Director and President, entered into a 10b5-1 sales plan (the “von Ahn 10b5-1 Sales Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, pursuant to which a maximum aggregate of 103,000 shares of the Company’s Class A common stock may be sold (up to 80,000 shares by Dr. von Ahn and up to 23,000 by the Luis von Ahn Foundation). The von Ahn 10b5-1 Sales Plan will remain in effect until the earlier of (1) December 15, 2024, (2) the date on which an aggregate of 103,000 shares of the Company’s common stock have been sold under the von Ahn 10b5-1 Sales Plan, or (3) such time as the von Ahn 10b5-1 Sales Plan is otherwise terminated or expires according to its terms.
Name Dr. Luis von Ahn,  
Title Chief Executive Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 30, 2023  
Arrangement Duration 397 days  
Aggregate Available 80,000 80,000
Amy Bohutinsky [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On December 4, 2023, Amy Bohutinsky, member of our Board of Directors, entered into a 10b5-1 sales plan (the “Bohutinsky 10b5-1 Sales Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act which provides for the potential exercise of vested stock options and the associated sale of up to 15,000 shares of the Company’s Class A common stock. The Bohutinsky 10b5-1 Sales Plan will remain in effect until the earlier of (1) December 31, 2024, (2) the date on which an aggregate of 15,000 shares of the Company’s Class A common stock have been sold under the Bohutinsky 10b5-1 Sales Plan, or (3) such time as the Bohutinsky 10b5-1 Sales Plan is otherwise terminated or expires according to its terms.
Name Amy Bohutinsky  
Title member of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 4, 2023  
Arrangement Duration 393 days  
Aggregate Available 15,000 15,000